SCHEMBL10488673

SCHEMBL10488673

Cc1c(Cl)cc(C(C)(C)C)c(O)c1Cl

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.65
CYP2C9 P11712 3/20 0.65
CYP2C19 P33261 3/20 0.65
HIF1A Q16665 2/20 0.65
TP53 P04637 1/20 0.65
CA2 P00918 4/20 0.50
ALDH1A1 P00352 3/20 0.50
POLB P06746 1/20 0.50
TYR P14679 1/20 0.50
CA1 P00915 2/20 0.46
CYP1A2 P05177 2/20 0.45
HSPA5 P11021 1/20 0.41
MAPT P10636 2/20 0.41
ALOX15 P16050 2/20 0.41
HPN P05981 1/20 0.41
SIRT5 Q9NXA8 1/20 0.41
GLRA3 O75311 1/20 0.39
GLRB P48167 1/20 0.39
KDM4E B2RXH2 1/20 0.39
ATP2A2 P16615 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10618591 0.85 SMN1; SMN2 (0.52) SMN1; SMN2CYP2C9CYP2C19HIF1ATP53
SCHEMBL24946528 0.83 SMN1; SMN2 (0.53) SMN1; SMN2CYP2C9CYP2C19HIF1ATP53
SCHEMBL27962109 0.82 SMN1; SMN2 (0.62) SMN1; SMN2CYP2C9CYP2C19HIF1ATP53
SCHEMBL28063692 0.80 SMN1; SMN2 (0.50) SMN1; SMN2CYP2C9CYP2C19HIF1ATP53
SCHEMBL9149388 0.80 CA2 (0.56) SMN1; SMN2CYP2C9CYP2C19HIF1ATP53
SCHEMBL3039574 0.79 SMN1; SMN2 (0.59) SMN1; SMN2CYP2C9CYP2C19HIF1ATP53
SCHEMBL70468 0.79 CYP2C19 (1.00) SMN1; SMN2CYP2C9CYP2C19HIF1ATP53
SCHEMBL9777384 0.77 SMN1; SMN2 (0.47) SMN1; SMN2CYP2C9CYP2C19HIF1ATP53
SCHEMBL1457169 0.76 GLRA3 (0.65) SMN1; SMN2CYP2C9CYP2C19HIF1ATP53
SCHEMBL1456500 0.76 SMN1; SMN2 (0.56) SMN1; SMN2CYP2C9CYP2C19HIF1ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4039587-A Method of preparing polynuclear, halogenated, aromatic benzyl ethers DYNAMIT NOBEL AKTIENGESELLSCHAFT (DT) 1977-08-02 US claimed
JP-63303941-A None JP disclosed
JP-63130549-A None JP disclosed
JP-1207253-A None JP disclosed
US-20230026611-A1 ARYL HETEROCYCLIC COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERS D. E. SHAW RESEARCH, LLC 2023-01-26 US disclosed
JP-H01207253-A PRODUCTION OF 2,4-DICHLORO-3-METHYLPHENOL SUMITOMO CHEM CO LTD 1989-08-21 JP disclosed
JP-S63303941-A PRODUCTION OF 2,4-DICHLORO-3-METHYLPHENOL SUMITOMO CHEM CO LTD 1988-12-12 JP disclosed
JP-S63130549-A PRODUCTION OF 2,4-DICHLORO-3-METHYLPHENOL SUMITOMO CHEM CO LTD 1988-06-02 JP disclosed
US-4039587-A Method of preparing polynuclear, halogenated, aromatic benzyl ethers DYNAMIT NOBEL AKTIENGESELLSCHAFT (DT) 1977-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230026611-A1 ARYL HETEROCYCLIC COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERS KCNA3, KCNH2, KCNJ2 SMN1; SMN2 2503/4885CYP2C9 599/4885CYP2C19 670/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.